P&PAULSON & CO. INC.
Institutional investor · Portfolio as of Q4 2025
Top Holdings9 positions
MADRIGAL PHARMACEUTICALS INC | 1.7M | $994.4M | 30.5% | $239.32 | +143.33% | 11 qtrssince 2023-Q2 | Decreased 0 |
PERPETUA RESOURCES CORP | 32.3M | $783.1M | 24.0% | $7.35 | +233.78% | 19 qtrssince 2021-Q1 | Unchanged 0 |
BAUSCH HEALTH COS INC | 73.3M | $509.1M | 15.6% | $11.64 | -39.93% | 25 qtrssince 2019-Q3 | Increased 66 |
BRIGHTSPHERE INVT GROUP INC | 7.7M | $363.9M | 11.2% | $9.52 | +391.47% | 25 qtrssince 2019-Q3 | Unchanged 0 |
NOVAGOLD RES INC | 27.2M | $253.9M | 7.8% | $5.90 | +59.93% | 25 qtrssince 2019-Q3 | Unchanged 0 |
AGNICO EAGLE MINES LTD | 783,561 | $132.8M | 4.1% | $55.39 | +204.11% | 16 qtrssince 2022-Q1 | Unchanged 0 |
INTERNATIONAL TOWER HILL MIN | 70.2M | $130.6M | 4.0% | $0.56 | +229.42% | 25 qtrssince 2019-Q3 | Unchanged 0 |
SOLSTICE ADVANCED MATLS INC | 1.4M | $67.8M | 2.1% | $48.43 | +56.92% | 1 qtr | New 80 |
THRYV HLDGS INC | 4.3M | $26.3M | 0.8% | $13.63 | -55.25% | 20 qtrssince 2020-Q4 | Increased 44 |
PAULSON & CO. INC. manages $3.3B across 9 positions as of Q4 2025. Top holdings: MDGL (30.5%), PPTA (24.0%), BHC (15.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Added 1 new position, exited 2, increased 2, trimmed 1. Top move: SOLS (NEW, conviction 80). Portfolio: $3.3B across 9 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR